Work

Single-Agent MOR208 in Relapsed or Refractory (R-R) Non-Hodgkin's Lymphoma (NHL): Results from Diffuse Large B-Cell Lymphoma (DLBCL) and Indolent NHL Subgroups of a Phase IIa Study

Year: 2016

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v128.22.623.623

Authors: Wojciech Jurczak, Pier Luigi Zinzani, Gianluca Gaidano, Andre Goy, Mariano Provencio, Zsolt Nagy, Tadeusz Robak, Kami J. Maddocks, Christian Buske, Sumeet Ambarkhane, Mark Winderlich, Maren Dirnberger-Hertweck, Jan Endell, Kristie A Blum

Institutions: Jagiellonian University, University of Bologna, Università degli Studi del Piemonte Orientale “Amedeo Avogadro”, Hackensack University Medical Center, Hospital Universitario Puerta de Hierro Majadahonda, Semmelweis University, Medical University of Lodz, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Universität Ulm, University Hospital Ulm, MorphoSys (Germany)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2606824928

FWCI: 1.783

Cites:

Cited by: 8

Related to: 10